Citation: Gm. Pasinetti et L. Ho, From cDNA microarrays to high-throughput proteomics. Implications in the search for preventive initiatives to slow the clinical progression of Alzheimer's disease dementia, REST NEUROL, 18(2-3), 2001, pp. 137-142
Citation: Gm. Pasinetti, Use of cDNA microarray in the search for molecular markers involved in theonset of Alzheimer's disease dementia, J NEUROSC R, 65(6), 2001, pp. 471-476
Authors:
Ho, L
Guo, YJ
Spielman, L
Petrescu, O
Haroutunian, V
Purohit, D
Czernik, A
Yemul, S
Aisen, PS
Mohs, R
Pasinetti, GM
Citation: L. Ho et al., Altered expression of a-type but not b-type synapsin isoform in the brain of patients at high risk for Alzheimer's disease assessed by DNA microarraytechnique, NEUROSCI L, 298(3), 2001, pp. 191-194
Citation: Gm. Pasinetti, Cyclooxygenase and Alzheimer's disease: implications for preventive initiatives to slow the progression of clinical dementia, ARCH GER G, 33(1), 2001, pp. 13-28
Citation: L. Ho et Gm. Pasinetti, The potential of selective COX-2 inhibitors in inflammatory and other diseases, DRUGS TODAY, 37(3), 2001, pp. 181-185
Citation: P. Mukherjee et Gm. Pasinetti, Complement anaphylatoxin C5a neuroprotects through mitogen-activated protein kinase-dependent inhibition of caspase 3, J NEUROCHEM, 77(1), 2001, pp. 43-49
Authors:
Ho, L
Purohit, D
Haroutunian, V
Luterman, JD
Willis, F
Naslund, J
Buxbaum, JD
Mohs, RC
Aisen, PS
Pasinetti, GM
Citation: L. Ho et al., Neuronal cyclooxygenase 2 expression in the hippocampal formation as a function of the clinical progression of Alzheimer disease, ARCH NEUROL, 58(3), 2001, pp. 487-492
Citation: Gm. Pasinetti, Cyclooxygenase (COX)-2 and clinical progression of Alzheimer's disease dementia: Implications in the role of neuronal COX-2 in cell cycle, ALZHEIMER'S DISEASE, 2001, pp. 379-392
Citation: P. Mukherjee et Gm. Pasinetti, The role of complement anaphylatoxin C5a in neurodegeneration: implications in Alzheimer's disease, J NEUROIMM, 105(2), 2000, pp. 124-130
Authors:
Luterman, JD
Haroutunian, V
Yemul, S
Purohit, D
Aisen, PS
Mohs, R
Pasinetti, GM
Citation: Jd. Luterman et al., Cytokine gene expression as a function of the clinical progression of Alzheimer disease dementia, ARCH NEUROL, 57(8), 2000, pp. 1153-1160
Authors:
Pasinetti, GM
Hassler, M
Stone, D
Finch, CE
Citation: Gm. Pasinetti et al., Glial gene expression during aging in rat striatum and in long-term responses to 6-OHDA lesions, SYNAPSE, 31(4), 1999, pp. 278-284
Authors:
Osaka, H
Mukherjee, P
Aisen, PS
Pasinetti, GM
Citation: H. Osaka et al., Complement-derived anaphylatoxin C5a protects against glutamate-mediated neurotoxicity, J CELL BIOC, 73(3), 1999, pp. 303-311
Authors:
Ho, L
Pieroni, C
Winger, D
Purohit, DP
Aisen, PS
Pasinetti, GM
Citation: L. Ho et al., Regional distribution of cyclooxygenase-2 in the hippocampal formation in Alzheimer's disease, J NEUROSC R, 57(3), 1999, pp. 295-303
Authors:
Osaka, H
McGinty, A
Hoepken, UE
Lu, B
Gerard, C
Pasinetti, GM
Citation: H. Osaka et al., Expression of C5a receptor in mouse brain: Role in signal transduction andneurodegeneration, NEUROSCIENC, 88(4), 1999, pp. 1073-1082
Authors:
Battaini, F
Pascale, A
Lucchi, L
Pasinetti, GM
Govoni, S
Citation: F. Battaini et al., Protein kinase C anchoring deficit in postmortem brains of Alzheimer's disease patients, EXP NEUROL, 159(2), 1999, pp. 559-564
Authors:
Chun, JT
Wang, L
Pasinetti, GM
Finch, CE
Zlokovic, BV
Citation: Jt. Chun et al., Glycoprotein 330/megalin (LRP-2) has low prevalence as mRNA and protein inbrain microvessels and choroid plexus, EXP NEUROL, 157(1), 1999, pp. 194-201
Authors:
Kelley, KA
Ho, L
Winger, D
Freire-Moar, J
Borelli, CB
Aisen, PS
Pasinetti, GM
Citation: Ka. Kelley et al., Potentiation of excitotoxicity in transgenic mice overexpressing neuronal cyclooxygenase-2, AM J PATH, 155(3), 1999, pp. 995-1004